Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
3.30
-0.13 (-3.79%)
At close: Jun 06, 2025, 3:59 PM
3.26
-1.21%
After-hours: Jun 06, 2025, 05:40 PM EDT
-3.79% (1D)
| Bid | 3.13 |
| Market Cap | 35.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.88M |
| EPS (ttm) | -1.84 |
| PE Ratio (ttm) | -1.79 |
| Forward PE | -2.13 |
| Analyst | Buy |
| Ask | 3.4 |
| Volume | 59,815 |
| Avg. Volume (20D) | 46,120 |
| Open | 3.31 |
| Previous Close | 3.43 |
| Day's Range | 3.27 - 3.36 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.54 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+9.06%
LTRN stock has given up its prior gain. Lantern Ph...
Unlock content with
Pro Subscription
1 week ago
+9.06%
Lantern Pharma shares are trading higher after the company announced preclinical data for LP-184.
